## Novel Drug Approvals for 2024

|     |           |                                   |               |                                                                                                                                                    |
| --- | --------- | --------------------------------- | ------------- | -------------------------------------------------------------------------------------------------------------------------------------------------- |
| No. | Drug Name | Active Ingredient                 | Approval Date | FDA-approved use on approval date\*                                                                                                                |
| 18. | Iqirvo    | elafibranor                       | 6/10/2024     | To treat primary biliary cholangitis in combination with ursodeoxycholic acid                                                                      |
| 17. | Rytelo    | imetelstat                        | 6/6/2024      | To treat low- to intermediate-1 risk myelodysplastic syndromes                                                                                     |
| 16. | Imdelltra | tarlatamab-dlle                   | 5/16/2024     | To treat extensive stage small cell lung cancer                                                                                                    |
| 15. | Xolremdi  | mavorixafor                       | 4/26/2024     | To treat WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis)                                                                |
| 14. | Ojemda    | tovorafenib                       | 4/23/2024     | To treat relapsed or refractory pediatric low-grade glioma                                                                                         |
| 13. | Anktiva   | nogapendekin alfa inbakicept-pmln | 4/22/2024     | To treat bladder cancer                                                                                                                            |
| 12. | Lumisight | pegulicianine                     | 4/17/2024     | To use as an optical imaging agent for the detection of cancerous tissue                                                                           |
| 11. | Zevtera   | ceftobiprole medocaril sodium     | 4/3/2024      | To treat certain bloodstream infections, bacterial skin and associated tissue infections, and community-acquired bacterial pneumoniaPress Release  |
| 10. | Voydeya   | danicopan                         | 3/29/2024     | To treat extravascular hemolysis with paroxysmal nocturnal hemoglobinuria                                                                          |
| 9.  | Vafseo    | vadadustat                        | 3/27/2024     | To treat anemia due to chronic kidney disease                                                                                                      |
| 8.  | Winrevair | sotatercept-csrk                  | 3/26/2024     | To treat pulmonary arterial hypertension                                                                                                           |
| 7.  | Duvyzat   | givinostat                        | 3/21/2024     | To treat Duchenne muscular dystrophy in individuals aged 6 years and olderPress ReleaseDrug Trials Snapshot                                        |
| 6.  | Tryvio    | aprocitentan                      | 3/19/2024     | To treat hypertension                                                                                                                              |
| 5.  | Rezdiffra | resmetirom                        | 3/14/2024     | To treat noncirrhotic non-alcoholic steatohepatitis with moderate to advanced liver scarringPress Release                                          |
| 4.  | Tevimbra  | tislelizumab-jsgr                 | 3/13/2024     | To treat unresectable or metastatic esophageal squamous cell carcinomaDrug Trials Snapshot                                                         |
| 3.  | Letybo    | letibotulinumtoxinA-wlbg          | 2/29/2024     | To temporarily improve the appearance of moderate-to-severe glabellar linesDrug Trials Snapshot                                                    |
| 2.  | Exblifep  | cefepime, enmetazobactam          | 2/22/2024     | To treat complicated urinary tract infections                                                                                                      |
| 1.  | Zelsuvmi  | berdazimer                        | 1/5/2024      | To treat molluscum contagiosumDrug Trials Snapshot                                                                                                 |

## Novel Drug Approvals for 2023

|     |           |                             |               |                                                                                                                                                                                                                                          |
| --- | --------- | --------------------------- | ------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| No. | Drug Name | Active Ingredient           | Approval Date | FDA-approved use on approval date\*                                                                                                                                                                                                      |
| 31. | Izervay   | avacincaptad pegol          | 8/4/2023      | To treat geographic atrophy secondary to age-related macular degeneration                                                                                                                                                                |
| 2.  | Brenzavvy | bexagliflozin               | 1/20/2023     | To improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exerciseDrug Trials Snapshot                                                                                                               |
| 43. | Bimzelx   | bimekizumab                 | 10/17/2023    | To treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapyDrug Trials Snapshot                                                                                                       |
| 54. | Filsuvez  | birch triterpenes           | 12/18/2023    | To treat wounds associated with dystrophic and junctional epidermolysis bullosaDrug Trials Snapshot                                                                                                                                      |
| 51. | Truqap    | capivasertib                | 11/16/2023    | To treat breast cancer that meets certain disease criteria                                                                                                                                                                               |
| 39. | Pombiliti | cipaglucosidase alfa-atga   | 9/28/2023     | To treat late-onset Pompe diseaseDrug Trials Snapshot                                                                                                                                                                                    |
| 5.  | Jesduvroq | daprodustat                 | 2/1/2023      | To treat anemia caused by chronic kidney disease for adults on dialysis for at least four monthsPress ReleaseDrug Trials Snapshot                                                                                                        |
| 50. | Ryzneuta  | efbemalenograstim alfa-vuxw | 11/16/2023    | To treat neutropeniaDrug Trials Snapshot                                                                                                                                                                                                 |
| 4.  | Orserdu   | elacestrant                 | 1/27/2023     | To treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated, advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapyDrug Trials Snapshot |
| 33. | Elrexfio  | elranatamab-bcmm            | 8/14/2023     | To treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapyDrug Trials Snapshot                                                                                                  |
| 18. | Epkinly   | epcoritamab-bysp            | 5/19/2023     | To treat relapsed or refractory diffuse large B-cell lymphoma (not otherwise specified) and high-grade B-cell lymphoma after two or more lines of systemic therapyDrug Trails Snapshots                                                  |
| 55. | Wainua    | eplontersen                 | 12/21/2023    | To treat polyneuropathy of hereditary transthyretin-mediated amyloidosisDrug Trials Snapshot                                                                                                                                             |
| 41. | Velsipity | etrasimod                   | 10/12/2023    | To treat moderately to severely active ulcerative colitis in adults                                                                                                                                                                      |
| 16. | Veozah    | fezolinetant                | 5/12/2023     | To treat moderate to severe hot flashes caused by menopausePress Release                                                                                                                                                                 |
| 21. | Posluma   | flotufolastat F 18          | 5/25/2023     | To use with positron emission tomography imaging in certain patients with prostate cancerDrug Trials Snapshot                                                                                                                            |
| 47. | Fruzaqla  | fruquintinib                | 11/8/2023     | To treat refractory, metastatic colorectal cancerDrug Trials Snapshot                                                                                                                                                                    |
| 38. | Exxua     | gepirone                    | 9/22/2023     | To treat major depressive disorder                                                                                                                                                                                                       |
| 23. | Columvi   | glofitamab-gxbm             | 6/15/2023     | To treat diffuse large B-cell lymphoma, not otherwise specified, or large B-cell lymphoma arising from follicular lymphoma after two or more lines of systemic therapyDrug Trials Snapshot                                               |
| 53. | Fabhalta  | iptacopan                   | 12/5/2023     | To treat paroxysmal nocturnal hemoglobinuria                                                                                                                                                                                             |
| 1.  | Leqembi   | lecanemab-irmb              | 1/6/2023      | To treat Alzheimer’s diseasePress Release                                                                                                                                                                                                |
| 13. | Joenja    | leniolisib                  | 3/24/2023     | To treat activated phosphoinositide 3-kinase delta syndromeDrug Trials Snapshots                                                                                                                                                         |
| 29. | Xdemvy    | lotilaner                   | 7/25/2023     | To treat Demodex blepharitis                                                                                                                                                                                                             |
| 45. | Omvoh     | mirikizumab-mrkz            | 10/26/2023    | To treat ulcerative colitis                                                                                                                                                                                                              |
| 37. | Ojjaara   | momelotinib                 | 9/15/2023     | To treat intermediate or high-risk myelofibrosis in adults with anemia                                                                                                                                                                   |
| 36. | Aphexda   | motixafortide               | 9/8/2023      | To use with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myelomaDrug Trials Snapshot                               |
| 40. | Rivfloza  | nedosiran                   | 9/29/2023     | To lower urinary oxalate levels in patients 9 years and older with primary hyperoxaluria type 1 and relatively preserved kidney functionDrug Trials Snapshot                                                                             |
| 20. | Paxlovid  | nirmatrelvir, ritonavir     | 5/25/2023     | To treat mild-to-moderate COVID-19 in adults at high risk for progression to severe COVID-19Press ReleaseDrug Trials Snapshot                                                                                                            |
| 52. | Ogsiveo   | nirogacestat                | 11/27/2023    | To treat adults with progressing desmoid tumors who require systemic treatmentDrug Trials Snapshot                                                                                                                                       |
| 27. | Beyfortus | nirsevimab-alip             | 7/17/2023     | To prevent respiratory syncytial virus (RSV) lower respiratory tract diseasePress ReleaseDrug Trials Snapshot                                                                                                                            |
| 8.  | Skyclarys | omaveloxolone               | 2/28/2023     | To treat Friedrich’s ataxiaDrug Trials Snapshots                                                                                                                                                                                         |
| 34. | Sohonos   | palovarotene                | 8/16/2023     | To reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for males) with fibrodysplasia ossificans progressiva                                   |
| 15. | Elfabrio  | pegunigalsidase alfa-iwxj   | 5/9/2023      | To treat confirmed Fabry disease                                                                                                                                                                                                         |
| 17. | Miebo     | perfluorhexyloctane         | 5/18/2023     | To treat signs and symptoms of dry eye disease                                                                                                                                                                                           |
| 3.  | Jaypirca  | pirtobrutinib               | 1/27/2023     | To treat relapsed or refractory mantle cell lymphoma in adults who have had at least two lines of systemic therapy, including a BTK inhibitorDrug Trials Snapshot                                                                        |
| 35. | Veopoz    | pozelimab-bbfg              | 8/18/2023     | To treat patients 1 year old and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease                                                                                                                |
| 28. | Vanflyta  | quizartinib                 | 7/20/2023     | To use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteriaDrug Trials Snapshot                                                                                                         |
| 49. | Augtyro   | repotrectinib               | 11/15/2023    | To treat ROS1-positive non-small cell lung cancerDrug Trials Snapshot                                                                                                                                                                    |
| 11. | Zynyz     | retifanlimab-dlwr           | 3/22/2023     | To treat metastatic or recurrent locally advanced Merkel cell carcinoma                                                                                                                                                                  |
| 12. | Rezzayo   | rezafungin                  | 3/22/2023     | To treat candidemia and invasive candidiasis                                                                                                                                                                                             |
| 24. | Litfulo   | ritlecitinib                | 6/23/2023     | To treat severely patchy hair lossDrug Trials Snapshot                                                                                                                                                                                   |
| 25. | Rystiggo  | rozanolixizumab-noli        | 6/26/2023     | To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor- or anti-muscle-specific tyrosine kinase antibody-positiveDrug Trials Snapshot                                                                      |
| 26. | Ngenla    | somatrogon-ghla             | 6/27/2023     | To treat growth failure due to inadequate secretion of endogenous growth hormoneDrug Trials Snapshot                                                                                                                                     |
| 22. | Inpefa    | sotagliflozin               | 5/26/2023     | ​To treat heart failure                                                                                                                                                                                                                  |
| 7.  | Filspari  | sparsentan                  | 2/17/2023     | To reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progressionDrug Trials Snapshot                                                                                                       |
| 19. | Xacduro   | sulbactam, durlobactam      | 5/23/2023     | To treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complexPress Release                                                |
| 32. | Talvey    | talquetamab-tgvs            | 8/9/2023      | To treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies                                                                                                                             |
| 48. | Defencath | taurolidine, heparin        | 11/15/2023    | To reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter                                                                        |
| 14. | Qalsody   | tofersen                    | 4/25/2023     | To treat amyotrophic lateral sclerosis in adults who have a SOD1 gene mutation                                                                                                                                                           |
| 46. | Loqtorzi  | toripalimab-tpzi            | 10/27/2023    | To treat recurrent or metastatic nasopharyngeal carcinoma when used together with or following other therapies                                                                                                                           |
| 10. | Daybue    | trofinetide                 | 3/10/2023     | To treat Rett syndrome                                                                                                                                                                                                                   |
| 44. | Agamree   | vamorolone                  | 10/26/2023    | To treat Duchenne muscular dystrophyDrug Trials Snapshot                                                                                                                                                                                 |
| 6.  | Lamzede   | velmanase alfa-tycv         | 2/16/2023     | To treat non-central nervous system manifestations of alpha-mannosidosis                                                                                                                                                                 |
| 9.  | Zavzpret  | zavegepant                  | 3/9/2023      | To treat migraine                                                                                                                                                                                                                        |
| 42. | Zilbrysq  | zilucoplan                  | 10/17/2023    | To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive                                                                                                                            |
| 30. | Zurzuvae  | zuranolone                  | 8/4/2023      | To treat postpartum depression Press ReleaseDrug Trials Snapshot                                                                                                                                                                         |
